Skip to main content
Earnings Labs
Inovio Pharmaceuticals, Inc. logo

Inovio Pharmaceuticals, Inc. (INO)

NASDAQ·Healthcare·Biotechnology

$0.95

+7.06%

Mkt Cap $57.96M

Analyst Ratings

Buy

2

Hold

1

Sell

0

Price Target (7 analysts)

$2.75

Range $2.50 – $3.00

Implied Upside

+188.6%

Consensus $2.75 vs current $0.95